Company intelligence / Profile preview

Institut de Recherches Internationales Servier

Suresnes, France
Ownership
Private
Employees
~21900
Development stage
Other
01

Overview

Servier is a global pharmaceutical group governed by a non-profit foundation, headquartered in France. The Institut de Recherches Internationales Servier (IRIS) serves as the group's primary international clinical research hub, driving the development of innovative medicines across oncology, cardiovascular, and neuroscience sectors. The company has a significant focus on hard-to-treat cancers, notably through its acquisition of Agios Pharmaceuticals' oncology business and Shire's oncology branch. Servier operates in over 150 countries and reinvests a high percentage of its revenue into R&D to address unmet medical needs. The organization is particularly recognized for its leadership in IDH-mutant cancers and its commitment to therapeutic areas including immuno-inflammation and neuropsychiatry.

Therapeutic areas
HematologyCardiovascularPsychiatryOncology
Modalities
Small moleculeMonoclonal antibodyCAR-T cell therapyCell therapyBispecific monoclonal antibodyAntisense oligonucleotide
Industry
Pharma
02

Drug pipeline

1 asset

S221237

Unknown
03

Partnerships

NovartisAmgenPfizerCellectisBioLabsVernalis

Beyond the preview

Go deeper on Institut de Recherches Internationales Servier.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Institut de Recherches Internationales Servier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call